Cost-effectiveness of adding new rotavirus vaccines to the national immunization program in Kyrgyzstan

被引：0
|
作者：
Flem, E. T. [1 ]
Latipov, R. [2 ]
Nurmativ, Z. S.
Xue, Y. [2 ]
Kasymbekova, K. T.
Rheingans, R. [3 ]
机构：
[1] Norwegian Inst Publ Hlth, Trondheim, Norway
[2] Univ Oslo, N-0316 Oslo, Norway
[3] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA
来源：
VACCINE | 2008年
关键词：
cost; rotavirus; vaccine; diarrhea;
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] THE THAI EXPANDED PROGRAM ON IMMUNIZATION - ROLE OF IMMUNIZATION SESSIONS AND THEIR COST-EFFECTIVENESS
    PHONBOON, K
    SHEPARD, DS
    RAMABOOT, S
    KUNASOL, P
    PREUKSARAJ, S
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 1989, 67 (02) : 181 - 188
  • [22] Economic analysis for national immunization program planning: A case of rotavirus vaccines in Burundi
    Niyibitegeka, Fulgence
    Riewpaiboon, Arthorn
    Youngkong, Sitaporn
    Thavorncharoensap, Montarat
    VACCINE, 2021, 39 (08) : 1272 - 1282
  • [23] REVIEW OF ADMINISTRATION'S COST ASSUMPTION OF ROTAVIRUS AND PNEUMOCOCCAL VACCINES COST-EFFECTIVENESS ANALYSES
    De la Hoz-Restrepo, F.
    Castaneda-Orjuela, C. A.
    Alvis, N.
    Paternina, A.
    VALUE IN HEALTH, 2012, 15 (04) : A162 - A162
  • [24] Impact and cost-effectiveness of rotavirus vaccination in Niger: a modelling study evaluating alternative rotavirus vaccines
    Debellut, Frederic
    Tang, Kevin
    Clark, Andrew
    Pecenka, Clint
    Assao, Bachir
    Guindo, Ousmane
    Grais, Rebecca F.
    Isanaka, Sheila
    BMJ OPEN, 2022, 12 (10):
  • [25] Distribution of Rotavirus Genotypes After Introduction of Rotavirus Vaccines, Rotarix® and RotaTeq®, into the National Immunization Program of Australia
    Kirkwood, Carl D.
    Boniface, Karen
    Barnes, Graeme L.
    Bishop, Ruth F.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2011, 30 (01) : S48 - S53
  • [26] VACCINES IN THE NATIONAL IMMUNIZATION PROGRAM
    BASS, AG
    PAPUA NEW GUINEA MEDICAL JOURNAL, 1993, 36 (02) : 141 - 157
  • [27] Rotavirus disease in Uzbekistan: Cost-effectiveness of a new vaccine
    Isakbaeva, E. T.
    Musabaev, E.
    Antil, L.
    Rheingans, R.
    Juraev, R.
    Glass, R. I.
    Bresee, J. S.
    VACCINE, 2007, 25 (02) : 373 - 380
  • [28] Cost-Effectiveness Analysis of the South African Infant National Immunization Program for the Prevention of Pneumococcal Disease
    Huang, Liping
    McDade, Cheryl L.
    Perdrizet, Johnna E.
    Wilson, Michele R.
    Warren, Sophie A.
    Nzenze, Susan
    Sewdas, Renilla
    INFECTIOUS DISEASES AND THERAPY, 2023, 12 (03) : 933 - 950
  • [29] Cost-Effectiveness Analysis of the South African Infant National Immunization Program for the Prevention of Pneumococcal Disease
    Liping Huang
    Cheryl L. McDade
    Johnna E. Perdrizet
    Michele R. Wilson
    Sophie A. Warren
    Susan Nzenze
    Renilla Sewdas
    Infectious Diseases and Therapy, 2023, 12 : 933 - 950
  • [30] Cost-effectiveness and budget impact analyses for the prioritisation of the four available rotavirus vaccines in the national immunisation programme in Thailand
    Luangasanatip, Nantasit
    Mahikul, Wiriya
    Poovorawan, Kittiyod
    Cooper, Ben S.
    Lubell, Yoel
    White, Lisa J.
    Teerawattananon, Yot
    Pan-Ngum, Wirichada
    VACCINE, 2021, 39 (09) : 1402 - 1414
12345